Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bert Vogelstein

Showing results (191-200 of 333) with videos related to

Pageof 34
Sort By:
Annals of Surgical Oncology|July 13, 2013
Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreasMarco Dal Molin, Hanno Matthaei, Jian Wu, et al.
Nature Cancer|February 5, 2022
Author Correction: Targeting public neoantigens for cancer immunotherapyAlexander H Pearlman, Michael S Hwang, Maximilian F Konig, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscapeAshley L Cook, Surojit Sur, Laura Dobbyn, et al.
Nature Communications|January 3, 2023
The rapid and highly parallel identification of antibodies with defined biological activities by SLISYSteve Lu, Austin K Mattox, P Aitana Azurmendi, et al.
Cancer Biology & Therapy|January 24, 2004
Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agentsLong H Dang, Chetan Bettegowda, Nishant Agrawal, et al.
Nature Cancer|October 22, 2021
Targeting public neoantigens for cancer immunotherapyAlexander H Pearlman, Michael S Hwang, Maximilian F Konig, et al.
Cancer Research|June 14, 2014
The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?Anne Marie Lennon, Christopher L Wolfgang, Marcia Irene Canto, et al.
Elife|February 17, 2025
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscapeAshley L Cook, Surojit Sur, Laura Dobbyn, et al.
Cancer Research|March 5, 2003
Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancersPaula M Hempen, Lin Zhang, Ravi K Bansal, et al.
Cancer Research|June 3, 2005
Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancersTuija Hienonen, Heli Sammalkorpi, Susa Enholm, et al.
Pageof 34

Showing results (191-200 of 333) with videos related to

Sort By:
Pageof 34
Annals of Surgical Oncology|July 13, 2013
Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreasMarco Dal Molin, Hanno Matthaei, Jian Wu, et al.
Nature Cancer|February 5, 2022
Author Correction: Targeting public neoantigens for cancer immunotherapyAlexander H Pearlman, Michael S Hwang, Maximilian F Konig, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscapeAshley L Cook, Surojit Sur, Laura Dobbyn, et al.
Nature Communications|January 3, 2023
The rapid and highly parallel identification of antibodies with defined biological activities by SLISYSteve Lu, Austin K Mattox, P Aitana Azurmendi, et al.
Cancer Biology & Therapy|January 24, 2004
Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agentsLong H Dang, Chetan Bettegowda, Nishant Agrawal, et al.
Nature Cancer|October 22, 2021
Targeting public neoantigens for cancer immunotherapyAlexander H Pearlman, Michael S Hwang, Maximilian F Konig, et al.
Cancer Research|June 14, 2014
The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?Anne Marie Lennon, Christopher L Wolfgang, Marcia Irene Canto, et al.
Elife|February 17, 2025
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscapeAshley L Cook, Surojit Sur, Laura Dobbyn, et al.
Cancer Research|March 5, 2003
Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancersPaula M Hempen, Lin Zhang, Ravi K Bansal, et al.
Cancer Research|June 3, 2005
Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancersTuija Hienonen, Heli Sammalkorpi, Susa Enholm, et al.
Pageof 34